Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012

@article{Kanba2013GuidelineFT,
  title={Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012},
  author={S. Kanba and Tadafumi Kato and T. Terao and Kazuo Yamada},
  journal={Psychiatry and Clinical Neurosciences},
  year={2013},
  volume={67}
}
The Japanese Society of Mood Disorders established a committee for treatment guidelines of mood disorders, which created the first edition of a treatment guideline for bipolar disorders on 10 March 2011. The committee has now created a second edition, which we report here. In creating this treatment guideline, the first step was to have several bipolar disorder specialists review well‐conducted studies and meta‐analyses. Based on this evidence, and with a consensus among the specialists… Expand

Topics from this paper

The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines.
TLDR
This paper compared and synthesized recommendations for the treatment of bipolar disorder made by recognized CPGs internationally across multiple clinical issues, including clinical indications, disorder subtypes, additional uses, special populations, practical aspects, and side effects. Expand
Acute pharmacological treatment strategies for bipolar depression
Besides maintaining long-term stability, the most difficult aspect in the management of bipolar affective disorder is the depressive phase. The similarities in the cluster of symptoms with unipolarExpand
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder
TLDR
Patients in a depressive state had a significantly higher rate of antidepressant prescriptions than patients with other mental states, and patients who were prescribed antidepressants received fewer mood stabilizers, more anxiolytics, and more hypnotics than those who did not receive antidepressant prescriptions. Expand
Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder?
TLDR
There is a lack of emphasis on early BD among widely-respected current clinical guidelines, likely reflecting the dearth of primary data, and future evidence or consensus-based recommendations could significantly inform clinical practice for this population. Expand
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
TLDR
Logistic regression analyses found the following eight factors to be significantly correlated with non-remission in patients with bipolar disorder: female gender, younger age, unemployed status, rapid cycling pattern, comorbid alcohol/substance abuse, poorer social function, lithium non-use, and antidepressant use. Expand
Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder
TLDR
The authors conclude that the real question is not whether ADs should or should not be used in bipolar depression, but which patients benefit from these drugs and which ones are impaired. Expand
Effectiveness of Simple Individual Psychoeducation for Bipolar II Disorder
TLDR
A successful case of simple individual psychoeducation with a patient with bipolar II disorder, a 64-year-old woman who had misconceptions surrounding her mood due to 24 years of treatment for depression, is reported. Expand
Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP).
TLDR
Several predictors identified in the present study may be useful in supporting a differential diagnosis of these disorders in routine clinical practice and in patients with a major depressive episode. Expand
Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report
TLDR
Older adults with bipolar disorder (OABD) are a growing segment of patients withipolar disorder (BD) for which specific guidelines are warranted, and it is expected that at least some of this emerging information on OABD would be incorporated into treatment guidelines available to clinicians around the world. Expand
Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?
TLDR
While there was some consistency across guidelines on key recommendations, there were also substantial inconsistencies, with the latter risking compromising clinical management. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 92 REFERENCES
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.
TLDR
These guidelines aim to provide recommendations that take into consideration the balance between safety and cost-effectiveness, to highlight iatrogenic and preventive clinical issues, and to facilitate the broad implementation of therapeutic safety monitoring as a standard component of treatment for bipolar disorder. Expand
Long‐term Use of Atypical Antipsychotics in Bipolar Disorder
TLDR
Although the APA guidelines provide sufficient evidence for the use of these mood stabilizers, newer drugs such as the atypical antipsychotics are being investigated for use in the maintenance phase of treatment of bipolar disorder. Expand
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
TLDR
The placebo-subtracted differences in body composition and metabolic parameters suggest utility for aripiprazole in the long-term treatment of bipolar disorder. Expand
Treatment of depression in bipolar disorder: new directions for research.
TLDR
There are few studies of treatment of the depressed phase of bipolar disorder, and their results generally are limited or inconclusive, but limited data on other antidepressant classes suggest that monoamine oxidase inhibitors, bupropion, and serotonergic agents may offer some advantages over tricyclic antidepressants in this population. Expand
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
TLDR
The use of adjunctive, standard antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy or with increased risk of treatment-emergent affective switch. Expand
Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
TLDR
Mood stabilizers have differing profiles of efficacy and tolerability, suggesting complementary roles in long-term maintenance treatment, according to systematic review of randomized controlled trials. Expand
Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis.
TLDR
It appears that psychoeducation plus medication can benefit bipolar II subjects, and dedicated treatment trials will need to clarify whether these therapies require modifications in duration and/or content to meet the needs of bipolar II patients. Expand
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines for the management of bipolar disorder in 2005, with a 2007 update. This second update, in conjunction with theExpand
A double- Blind placebo-controlled study of lamotriqine monotherapy outpatients with bipolar I depression
TLDR
Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar I depression and demonstrates significant antidepressant efficacy on the 17-item Hamilton Rating Scale for Depression and MADRS compared with placebo. Expand
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year.
TLDR
The findings support the conclusion that CT specifically designed for relapse prevention in bipolar affective disorder is a useful tool in conjunction with mood stabilizers. Expand
...
1
2
3
4
5
...